Jen-Sing Liu

Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia

Arthur E. Frankel, Jen-Sing Liu, David A. Rizzieri et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2008 · 151 citations

Antibody Internalization after Cell Surface Antigen Binding is Critical for Immunotoxin Development

Shu-Ru Kuo, Randall W. Alfano, Arthur E. Frankel et al. · Bioconjugate Chemistry · 2009 · 22 citations

Immunocytochemical Technique, Immunology, Immunodominance +19

GMP production and characterization of the bivalent anti-human T cell immunotoxin, A-dmDT390-bisFv(UCHT1) for phase I/II clinical trials

Jung Hee Woo, Jen-Sing Liu, Soo Hyun Kang et al. · Protein Expression and Purification · 2007 · 22 citations

Autoimmune Disease, Allergy, Immunology +10

Preclinical studies in rats and squirrel monkeys for safety evaluation of the bivalent anti-human T cell immunotoxin, A-dmDT390–bisFv(UCHT1)

Jung Hee Woo, Sarah H. Bour, Tony Dang et al. · Cancer Immunology Immunotherapy · 2008 · 22 citations · Full text

Allergy, Immunotoxicology, Preclinical Studies +13

Anti-caveolin-1 Antibodies As Anti-Prostate Cancer Therapeutics

Shu-Ru Kuo, Salahaldin A. Tahir, Sanghee Park et al. · Hybridoma · 2012 · 15 citations